tiprankstipranks
Trending News
More News >
China NT Pharma Group Co., Ltd. (HK:1011)
:1011
Hong Kong Market

China NT Pharma Group Co., Ltd. (1011) Income Statement

Compare
1 Followers

China NT Pharma Group Co., Ltd. Income Statement

Last quarter (Q4 2024), China NT Pharma Group Co., Ltd.'s total revenue was ¥6.66M, a decrease of -94.47% from the same quarter last year. In Q4, China NT Pharma Group Co., Ltd.'s net income was ¥-54.02M. See China NT Pharma Group Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 37.96M¥ 7.37M¥ 207.09M¥ 226.70M¥ 221.73M
Gross Profit
¥ 5.26M¥ 7.37M¥ 125.29M¥ 145.46M¥ 134.90M
Operating Expenses
¥ 18.49M¥ 63.57M¥ 117.56M¥ 228.39M¥ 217.82M
Depreciation and Amortization
¥ 4.58M¥ 5.88M¥ 21.07M¥ 42.25M¥ 24.40M
EBITDA
¥ -8.65M¥ 1.33M¥ 10.39M¥ -17.78M¥ -43.74M
Operating Income
¥ -13.23M¥ -56.21M¥ 18.44M¥ -59.28M¥ -68.13M
Other Income/Expenses
¥ -40.25M¥ 22.84M¥ -23.50M¥ -89.47M¥ -117.37M
Pretax Income
¥ -53.48M¥ -33.37M¥ -54.30M¥ -148.75M¥ -200.29M
Net Income
¥ -53.36M¥ -143.59M¥ -66.41M¥ -151.33M¥ -191.27M
Per Share Metrics
Basic EPS
¥ -0.20¥ -0.17¥ -0.04¥ -0.08¥ -0.10
Diluted EPS
¥ -0.20¥ -0.73¥ -0.04¥ -0.08¥ -0.10
Weighted Average Shares Outstanding
264.09M 848.12M 1.90B 1.89B 1.89B
Weighted Average Shares Outstanding (Diluted)
264.09M 197.82M 1.90B 1.89B 1.89B
Currency in CNY

China NT Pharma Group Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis